SRZN SURROZEN
Health Care · Russell 2000
Next earnings: not announced yet
What 8 analyst firms say about SURROZEN: their latest ratings, price targets and how far the stock is from them. How it works
Analyst window: Latest analyst report within last 1 year
Analyst view · last 1Y
7 rated views · 8 analyst/firm records · 8 firms
Radar score
- Russell 2000 · Top Picks · 6MBelow the Radar threshold of 8055
- Russell 2000 · Safest consensus · 6MBelow the Radar threshold of 8045
Recent analyst activity · last 90 days
Our tracked history has 6 reports on SRZN from 5 analyst firms in the last 90 days (8 firms in the past year).
Comparing each firm's latest target with its previous one: 1 raised its price target, 1 left it unchanged and 2 have their first observed target in the past year.
No firm's latest available rating differs from its previous one.
Latest observed target change: HC Wainwright raised its target from $44.00 (set 7 May 2026) to $54.00 on 25 Sep 2026.
Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.
| Firm | Analyst | Latest rating | Report date | Latest target (USD) |
|---|---|---|---|---|
| Cantor Fitzgerald | Steve Seedhouse | Buy | 12 Oct 2026 | 40.00 USD |
| Guggenheim | Yatin Suneja | Buy | 10 Aug 2026 | 42.00 USD |
| H.C. Wainwright | Matthew Caufield | Buy | 25 Sep 2026 | 54.00 USD |
| Lifesci Capital | Patrick Dolezal | Buy | 23 Mar 2026 | 44.00 USD |
| TD Cowen | Phil Nadeau | Buy | 21 Apr 2026 | — |
| Weiss Ratings | Unnamed analyst | — | 15 Oct 2026 | — |
| William Blair | Lachlan Hanbury-Brown | Buy | 20 Aug 2026 | 51.00 USD |
| Data feed RESEARCH | Research Team | Hold | 28 Jul 2026 | — |
Partial coverage · checked 6 Nov (6 Nov 2026, 07:02 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.